G. Barosi

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Paola Guglielmelli, Terra L. Lasho, Giada Rotunno et al. · Leukemia · 2014 · 307 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

Ercole Brusamolino, Almalina Bacigalupo, G. Barosi et al. · Haematologica · 2009 · 67 citations · Full text

Elderly Patients, Pathology, Immunotherapy +16

Guidelines for the use of recombinant human erythropoietin.

G. Barosi, Mario Cazzola, Amedeo De Vincentiis et al. · PubMed · 1995 · 18 citations

Translational Medicine, Urology, Ecombinant Human Erythropoietin +15

Serum procollagen‐III‐peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia

G. Barosi, A. Costa, Lucio N. Liberato et al. · British Journal of Haematology · 1989 · 12 citations

Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis

Damiano Rondelli, Judith D. Goldberg, Roberto Marchioli et al. · Biology of Blood and Marrow Transplantation · 2012 · 10 citations · Full text